鹿間 直人 しかま なおと 先生

来歴等

略歴

1987年 信州大学医学部 卒業
1987年 信州大学医学部附属病院 放射線科 勤務
1998年 米国 MD.アンダーソン癌センター、フォックスチェイス癌センター 留学
2009年 聖路加国際病院 放射線腫瘍科 医長
2010年 佐久総合病院 放射線腫瘍科 部長
2011年 埼玉医科大学国際医療センター 放射線腫瘍科 教授
2017年 順天堂大学医学部放射線医学教室・放射線治療学講座 教授
2022年 順天堂大学医学部放射線医学教室・放射線治療学講座 主任教授

論文

• 1. Optimizing dwell time weight for interstitial needles in intracavitary/interstitial hybrid brachytherapy: balancing tumor coverage with organ sparing using the inverse planning Technique. J Radiat Res. 2025;66: 296305.

  Takatsu J, Murakami N, Okonogi N, Inoue T, Iijima K, Muramoto Y, Kosugi Y, Kawamoto T, Karino T, Terao Y, Shikama N.

• 2. Efficacy and safety of FDG‑PET for determining target volume during intensity‑modulated radiotherapy for head and neck cancer involving the oral level. EJNMMI Rep. 2024;8: 6.

  Kosugi Y, Sasai K, Murakami N, KarinoT, Muramoto Y, Kawamoto T, Oshima M, Okonogi N, Takatsu J, Iijima K, Karube S, Isobe A, Hara B, Fujimaki M, Ohba S, Matsumoto F, Murakami K, Shikama N.

• 3. A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer.

  Nakamura K. Nihei K. Saito Y. Shikama N. Noda S. Hara R. Imagumbai T.　Mizowaki T. Akiba T. Kunieda E. Someya M. Ohga S. Kawamori J. Kozuka T. Ota Y. Inaba K. Kodaira T. Itoh Y. Funakoshi K. Kagami Y.A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer. Int. J. Clin. Oncol. 2024;29: 847-52.

• 4. Incidence of and risk factors for non-hematologic toxicity with combined radiotherapy and CDK4/6 inhibitors in metastatic breast cancer using dose-volume parameters analysis: a multicenter cohort study.

  Kawamoto T, Shikama N, Imano N, Kubota H, Kosugi T, Sekii S, Harada H, Yamada K, Naoi Y, Miyazawa K, Hirano Y, Wada Y, Tonari A, Saito T, Uchida N, Araki N, Nakamura N. Breast Cancer 2023;30:282-92.

• 5. Development of deep-inspiration breath-hold system that monitors the position of the chest wall using infrared rangefinder. Oshima M, Shikama N, Usui K, Nojiri S, IsobeA, MuramotoY, Kawamoto T, Yamaguchi N, Kosugi Y, Sasai K. J. Radiat. Res. 2023;64: 171-9. 6. Income and employment of patients at the start of and during follow-up after palliative radiation therapy for bone metastasis.

  Oshima M, Shikama N, Usui K, Nojiri S, IsobeA, MuramotoY, Kawamoto T, Yamaguchi N, Kosugi Y, Sasai K. J. Radiat. Res. 2023;64: 171-9.

• 6. Income and employment of patients at the start of and during follow-up after palliative radiation therapy for bone metastasis.

  Shirato H, Harada H, Iwasaki Y, Notsu A, Yamada K, Uezono H, Koide Y, Wada H, Kubota H, Shikama N, Yamazaki T, Ito K, Heianna J, Okada Y, Tonarin A, Takahashi S, Kosugi T, Ejima Y, Katoh N, Yoshida K, Shigematsu N. Adv Radiat Oncol 2023;8: 101205.

• 7. Metastasis-directed therapy for oligometastases in breast cancer.

  Ishiba T, Nishibuchi I, Hara F, Shikama N, Shien T, Iwata H. Jpn. J. Clin. Oncol. 2023;53: 893-8.

• 8. Who should receive single-fraction palliative radiotherapy for gastric cancer bleeding?: An exploratory analysis of a multicenter prospective observational study (JROSG 17-3).

  Sekii S, Saito T, Kosugi T, Nakamura N, Wada H, Tonari A, Ogawa H, Mitsuhashi N, Yamada K, Takahashi T, Ito K, Kawamoto T, Araki N, Nozaki M, Heianna J, Murotani K, Hirano Y, Satoh A, Onoe T, Shikama N. Clin Transl Radiat Oncol 2023;42: 100657.

• 9. Long-Term Follow-up of a Randomized Controlled Trial on Accelerated Radiation Therapy Versus Standard Fractionated Radiation Therapy for Early Glottic Cancer (JCOG0701A3).

  Kodaira T, Kagami Y, Machida R, Shikama N, Sekino Y, Ito Yoshinori, Ishikura S, Saito Yoshihiro, Matsumoto Y, Konishi K, Murakami N, Akimoto T, Fukushima Y, Toshiyasu T, Katano A, Nagata Y, Ogawa H, Uno T, Hamamoto Y, Nishimura Y, Mizowaki T. Int J Radiat Oncol Biol Phys 2023:117; 1118-24.

• 10. Treatment response after palliative radiotherapy for bleeding gastric cancer: a multicenter prospective observational study (JROSG 17 3).

  Saito T, Kosugi T, Nakamura N, Wada H, Tonari A, Ogawa H, Mitsuhashi N, Yamada K, Takahashi T, Ito K, Sekii S, Araki N, Nozaki M, Heianna J, Murotani K, Yasuhiro Y, Satoh A, Onoe T, Watakabe T, Shikama N. Gastric Cancer 2022;25: 411-21.

• 11. A Prospective study of reduced-dose three-course chop followed by involved-field radiotherapy for patients 70 years old or more with localized aggressive non-Hodgkin's lymphoma.

  Shikama N, Oguchi M, Isobe K, Nakamura K, Tamaki Y, Hasegawa M, Kodaira T, Sasaki S, Kagami Y; Japan Radiation Oncology Group (JAROG). Int J Radiat Oncol Biol Phys 2006;66: 217-22.

• 12. Lack of benefit of spinal irradiation in the primary treatment of intracranial germinoma.

  Shikama N, Ogawa K, Tanaka S, Toita T, Nakamura K, Uno T, Ohnishi H, Itami J, Tada T, Saeki N. Cancer 2005:104: 126-34.

著書

• 1. 鹿間直人 放射線療法 放射線肺臓炎 成人看護学２ 呼吸器、医学書院 2022年

• 2. 鹿間直人 造血器腫瘍 放射線治療学（改訂6版）南山堂 2017年

• 3. Shikama N, Miyazawa K. Cutaneous lymphoma. Radiation Therapy for Extranodal Lymphoma. 2017年

受賞

• 第1回優秀査読者賞（日本放射線腫瘍学会）2016年11月25日

SNS・ブログ等

• その他メディア
  • がんの放射線治療の「い・ろ・は」（動画）
  • すべての人に身近な「がん」を治すために ～「放射線療法」という選択～ ｜ 順天堂 GOOD HEALTH JOURNAL（記事）
  • すべての人に身近な「がん」を治すために ～「放射線療法」という選択～（動画）